STOCK TITAN

Insmed (NASDAQ: INSM) insider files to sell 795 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

INSM insider Martina Flammer filed a notice to sell 795 shares of common stock through Merrill Lynch on or about 02/03/2026 on NASDAQ, with an aggregate market value of 123,837 and 213,273,469 shares outstanding. The 795 shares were acquired on 02/01/2026 via stock plan activity from the issuer.

Over the prior three months, Flammer has sold multiple blocks of INSM common stock, including 31,226 shares on 11/11/2025 for gross proceeds of 5,921,820 and 12,303 shares on 01/05/2026 for gross proceeds of 2,108,459.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the INSM Form 144 filing by Martina Flammer disclose?

The Form 144 discloses that insider Martina Flammer intends to sell 795 INSM common shares through Merrill Lynch on or about 02/03/2026 on NASDAQ. These shares were acquired via stock plan activity on 02/01/2026 directly from the issuer.

How many INSM shares is the insider currently planning to sell?

The filing shows a planned sale of 795 INSM common shares. The notice lists an aggregate market value of 123,837 for this block, with trades to be executed through Merrill Lynch and the shares listed on NASDAQ.

How many INSM shares are outstanding according to this Form 144?

The Form 144 lists 213,273,469 INSM common shares as outstanding. This figure provides context for the planned 795-share sale, indicating the sale is small relative to the total share count referenced in the notice.

How were the 795 INSM shares to be sold acquired by the insider?

The 795 INSM common shares were acquired on 02/01/2026 through a stock plan activity transaction directly from the issuer. The form identifies the issuer as the source and classifies the acquisition as stock plan related, with payment dated the same day.

What prior INSM share sales by Martina Flammer are disclosed in the last 3 months?

The filing lists several prior INSM common stock sales, including 31,226 shares on 11/11/2025 for gross proceeds of 5,921,820 and 12,303 shares on 01/05/2026 for gross proceeds of 2,108,459, among other transactions.

Which broker and exchange are involved in the planned INSM share sale?

The Form 144 identifies Merrill Lynch, located at 1800 K St NW, Suite 800, Washington DC 20006, as the broker handling the planned sale of 795 INSM common shares. The shares are listed for trading on the NASDAQ exchange.
Insmed Inc

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Latest SEC Filings

INSM Stock Data

33.52B
210.97M
0.65%
101.25%
5%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER